Improving cancer drug development for diverse populations

Core 2: Research Education

NIH-funded research Beckman Research Institute/city of Hope · NIH-10933474

This study is working to make cancer treatments better for everyone by getting more Latino/Hispanic and African-American people involved in cancer research, so that the next generation of researchers can create therapies that work well for all communities.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBeckman Research Institute/city of Hope NIH-funded
Lab location1 site (Duarte, United States)
Project IDNIH-10933474 on NIH RePORTER

What this research studies

This research aims to address the disparities in cancer drug development that predominantly favor European-Americans by enhancing the participation of Latino/Hispanic-American and African-American communities. The project focuses on building a collaborative research infrastructure between the University of California at Riverside and the City of Hope Comprehensive Cancer Center. It will involve creating training programs and educational outreach to cultivate a new generation of therapeutics researchers who reflect the ethnic diversity of Inland Southern California. By integrating research experiences and curriculum development, the initiative seeks to ensure that future cancer treatments are more inclusive and effective for all populations.

Who could benefit from this research

Good fit: Ideal candidates for this research are Latino/Hispanic-American and African-American individuals who are affected by cancer.

Not a fit: Patients who are not part of the Latino/Hispanic-American or African-American communities may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and equitable cancer treatments tailored to diverse populations.

How similar studies have performed: Other research initiatives have shown success in addressing health disparities through community engagement and inclusive research practices.

Where this research is happening

Duarte, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.